IBU-TEC ADVANCED MATERIALS A(FRA:IBU) stock Fundamental Analysis

Fundamental Rating

Taking everything into account, IBU scores 3 out of 10 in our fundamental rating. IBU was compared to 62 industry peers in the Chemicals industry. IBU scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, IBU is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

IBU had negative earnings in the past year.

In the past year IBU had a positive cash flow from operations.

In multiple years IBU reported negative net income over the last 5 years.

The reported operating cash flow has been mixed in the past 5 years: IBU reported negative operating cash flow in multiple years.

1.2 Ratios

With a Return On Assets value of -7.79%, IBU is not doing good in the industry: 70.97% of the companies in the same industry are doing better.

Looking at the Return On Equity, with a value of -11.23%, IBU is doing worse than 64.52% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-7.79%
ROE	-11.23%
ROIC	N/A

ROA(3y)-0.63%

ROA(5y)0.31%

ROE(3y)-0.87%

ROE(5y)0.63%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

IBU has a Gross Margin of 48.03%. This is in the better half of the industry: IBU outperforms 66.13% of its industry peers.

In the last couple of years the Gross Margin of IBU has declined.

IBU does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	48.03%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.39%

GM growth 5Y-5.74%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

IBU does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for IBU remains at a similar level compared to 1 year ago.

The number of shares outstanding for IBU has been increased compared to 5 years ago.

The debt/assets ratio for IBU is higher compared to a year ago.

2.2 Solvency

An Altman-Z score of 2.43 indicates that IBU is not a great score, but indicates only limited risk for bankruptcy at the moment.

IBU has a Altman-Z score of 2.43. This is in the better half of the industry: IBU outperforms 61.29% of its industry peers.

IBU has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.

IBU has a better Debt to Equity ratio (0.20) than 79.03% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.2
Debt/FCF	N/A
Altman-Z	2.43

ROIC/WACCN/A

WACC6.73%

2.3 Liquidity

A Current Ratio of 9.62 indicates that IBU has no problem at all paying its short term obligations.

With an excellent Current ratio value of 9.62, IBU belongs to the best of the industry, outperforming 98.39% of the companies in the same industry.

IBU has a Quick Ratio of 3.41. This indicates that IBU is financially healthy and has no problem in meeting its short term obligations.

IBU has a better Quick ratio (3.41) than 93.55% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	9.62
Quick Ratio	3.41

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

IBU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -615.43%.

The Revenue has decreased by -3.87% in the past year.

The Revenue has been growing by 8.17% on average over the past years. This is quite good.

EPS 1Y (TTM)-615.43%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-945.86%

Revenue 1Y (TTM)-3.87%

Revenue growth 3Y13.53%

Revenue growth 5Y8.17%

Sales Q2Q%-1.92%

3.2 Future

IBU is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.38% yearly.

IBU is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.11% yearly.

EPS Next Y-116.13%

EPS Next 2Y-28.26%

EPS Next 3Y12.38%

EPS Next 5YN/A

Revenue Next Year9.94%

Revenue Next 2Y9.09%

Revenue Next 3Y13.11%

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IBU. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IBU. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IBU indicates a slightly more expensive valuation: IBU is more expensive than 62.90% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	134.04

4.3 Compensation for Growth

IBU's earnings are expected to grow with 12.38% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-28.26%

EPS Next 3Y12.38%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

With a yearly dividend of 0.18%, IBU is not a good candidate for dividend investing.

Compared to an average industry Dividend Yield of 3.07, IBU is paying slightly less dividend.

Compared to an average S&P500 Dividend Yield of 2.46, IBU's dividend is way lower than the S&P500 average.

		Industry Rank	Sector Rank
Dividend Yield	0.18%

5.2 History

Dividend Growth(5Y)N/A

Div Incr Years0

Div Non Decr Years0

5.3 Sustainability

DP0%

EPS Next 2Y-28.26%

EPS Next 3Y12.38%

More info and screens

Find the best dividend stocks

Show peers with best dividend

IBU-TEC ADVANCED MATERIALS A

FRA:IBU (4/28/2025, 7:00:00 PM)

5.72

+0.06 (+1.06%)

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)03-25 2025-03-25/amc

Earnings (Next)08-25 2025-08-25

Inst Owners6.58%

Inst Owner ChangeN/A

Ins Owners48.12%

Ins Owner ChangeN/A

Market Cap27.17M

Analysts45.71

Price Target7.55 (31.99%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0.18%

Yearly Dividend0.04

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)-116.13%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.57
P/FCF	N/A
P/OCF	4.62
P/B	0.51
P/tB	0.54
EV/EBITDA	134.04

EPS(TTM)-1.27

EYN/A

EPS(NY)-1.03

Fwd EYN/A

FCF(TTM)-0.09

FCFYN/A

OCF(TTM)1.24

OCFY21.64%

SpS10.05

BVpS11.28

TBVpS10.5

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-7.79%
ROE	-11.23%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	48.03%
FCFM	N/A

ROA(3y)-0.63%

ROA(5y)0.31%

ROE(3y)-0.87%

ROE(5y)0.63%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.39%

GM growth 5Y-5.74%

F-Score4

Asset Turnover0.62

Health

		Industry Rank	Sector Rank
Debt/Equity	0.2
Debt/FCF	N/A
Debt/EBITDA	42.97
Cap/Depr	129.25%
Cap/Sales	13.2%
Interest Coverage	N/A
Cash Conversion	2321.36%
Profit Quality	N/A
Current Ratio	9.62
Quick Ratio	3.41
Altman-Z	2.43

F-Score4

WACC6.73%

ROIC/WACCN/A

Cap/Depr(3y)154.81%

Cap/Depr(5y)139.05%

Cap/Sales(3y)14.7%

Cap/Sales(5y)13.72%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-615.43%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-945.86%

EPS Next Y-116.13%

EPS Next 2Y-28.26%

EPS Next 3Y12.38%

EPS Next 5YN/A

Revenue 1Y (TTM)-3.87%

Revenue growth 3Y13.53%

Revenue growth 5Y8.17%

Sales Q2Q%-1.92%

Revenue Next Year9.94%

Revenue Next 2Y9.09%

Revenue Next 3Y13.11%

Revenue Next 5YN/A

EBIT growth 1Y-554.35%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year138.89%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y95.78%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y226.53%

OCF growth 3Y-18.58%

OCF growth 5Y-6.12%

IBU-TEC ADVANCED MATERIALS A (IBU.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens